These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 38825240)
1. The effectiveness of vaccination on the COVID-19 epidemic in California. Huang E; Kurkure S; Seo Y; Lau K; Puglisi J Am J Infect Control; 2024 Nov; 52(11):1252-1257. PubMed ID: 38825240 [TBL] [Abstract][Full Text] [Related]
2. COVID-19 Cases and Hospitalizations by COVID-19 Vaccination Status and Previous COVID-19 Diagnosis - California and New York, May-November 2021. León TM; Dorabawila V; Nelson L; Lutterloh E; Bauer UE; Backenson B; Bassett MT; Henry H; Bregman B; Midgley CM; Myers JF; Plumb ID; Reese HE; Zhao R; Briggs-Hagen M; Hoefer D; Watt JP; Silk BJ; Jain S; Rosenberg ES MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(4):125-131. PubMed ID: 35085222 [TBL] [Abstract][Full Text] [Related]
3. Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022. Modes ME; Directo MP; Melgar M; Johnson LR; Yang H; Chaudhary P; Bartolini S; Kho N; Noble PW; Isonaka S; Chen P MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(6):217-223. PubMed ID: 35143466 [TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 Infections and Hospitalizations Among Persons Aged ≥16 Years, by Vaccination Status - Los Angeles County, California, May 1-July 25, 2021. Griffin JB; Haddix M; Danza P; Fisher R; Koo TH; Traub E; Gounder P; Jarashow C; Balter S MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(34):1170-1176. PubMed ID: 34437525 [TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 Infection and Hospitalization Among Adults Aged ≥18 Years, by Vaccination Status, Before and During SARS-CoV-2 B.1.1.529 (Omicron) Variant Predominance - Los Angeles County, California, November 7, 2021-January 8, 2022. Danza P; Koo TH; Haddix M; Fisher R; Traub E; OYong K; Balter S MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(5):177-181. PubMed ID: 35113851 [TBL] [Abstract][Full Text] [Related]
6. Shift in SARS-CoV-2 variants of concern from Delta to Omicron was associated with reduced hospitalizations, increased risk of breakthrough infections but lesser disease severity. Mwendwa F; Kanji A; Bukhari AR; Khan U; Sadiqa A; Mushtaq Z; Nasir N; Mahmood SF; Aamir UB; Hasan Z J Infect Public Health; 2024 Jun; 17(6):1100-1107. PubMed ID: 38714122 [TBL] [Abstract][Full Text] [Related]
7. Disease severity and efficacy of homologous vaccination among patients infected with SARS-CoV-2 Delta or Omicron VOCs, compared to unvaccinated using main biomarkers. Ali AM; Tofiq AM; Rostam HM; Ali KM; Tawfeeq HM J Med Virol; 2022 Dec; 94(12):5867-5876. PubMed ID: 36029103 [TBL] [Abstract][Full Text] [Related]
8. Comprehensive statistical analysis reveals significant benefits of COVID-19 vaccination in hospitalized patients: propensity score, covariate adjustment, and feature importance by permutation. de Moraes EV; Pires MC; Costa AAA; Nunes AGS; de Amorim CL; Manenti ERF; Lucas FB; Rodrigues FD; Anschau F; do Nascimento GF; Vietta GG; Moreira JFB; Ruschel KB; Costa MA; Duraes PAA; Van Der Sand Germani PA; Dos Reis PP; Menezes RM; da Rocha LCD; Gonçalves MA; Tupinambas U; Marcolino MS BMC Infect Dis; 2024 Sep; 24(1):1052. PubMed ID: 39333931 [TBL] [Abstract][Full Text] [Related]
9. Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022. Thompson MG; Natarajan K; Irving SA; Rowley EA; Griggs EP; Gaglani M; Klein NP; Grannis SJ; DeSilva MB; Stenehjem E; Reese SE; Dickerson M; Naleway AL; Han J; Konatham D; McEvoy C; Rao S; Dixon BE; Dascomb K; Lewis N; Levy ME; Patel P; Liao IC; Kharbanda AB; Barron MA; Fadel WF; Grisel N; Goddard K; Yang DH; Wondimu MH; Murthy K; Valvi NR; Arndorfer J; Fireman B; Dunne MM; Embi P; Azziz-Baumgartner E; Zerbo O; Bozio CH; Reynolds S; Ferdinands J; Williams J; Link-Gelles R; Schrag SJ; Verani JR; Ball S; Ong TC MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(4):139-145. PubMed ID: 35085224 [TBL] [Abstract][Full Text] [Related]
10. COVID-19-Associated Hospitalizations Among Adults During SARS-CoV-2 Delta and Omicron Variant Predominance, by Race/Ethnicity and Vaccination Status - COVID-NET, 14 States, July 2021-January 2022. Taylor CA; Whitaker M; Anglin O; Milucky J; Patel K; Pham H; Chai SJ; Alden NB; Yousey-Hindes K; Anderson EJ; Teno K; Reeg L; Como-Sabetti K; Bleecker M; Barney G; Bennett NM; Billing LM; Sutton M; Talbot HK; McCaffrey K; Havers FP; MMWR Morb Mortal Wkly Rep; 2022 Mar; 71(12):466-473. PubMed ID: 35324880 [TBL] [Abstract][Full Text] [Related]
11. Decrease in COVID-19 adverse outcomes in adults during the Delta and Omicron SARS-CoV-2 waves, after vaccination in Mexico. Domínguez-Ramírez L; Solis-Tejeda I; Ayon-Aguilar J; Mayoral-Ortiz A; Sosa-Jurado F; Pelayo R; Santos-López G; Cortes-Hernandez P Front Public Health; 2022; 10():1010256. PubMed ID: 36176536 [TBL] [Abstract][Full Text] [Related]
12. Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022. Ferdinands JM; Rao S; Dixon BE; Mitchell PK; DeSilva MB; Irving SA; Lewis N; Natarajan K; Stenehjem E; Grannis SJ; Han J; McEvoy C; Ong TC; Naleway AL; Reese SE; Embi PJ; Dascomb K; Klein NP; Griggs EP; Konatham D; Kharbanda AB; Yang DH; Fadel WF; Grisel N; Goddard K; Patel P; Liao IC; Birch R; Valvi NR; Reynolds S; Arndorfer J; Zerbo O; Dickerson M; Murthy K; Williams J; Bozio CH; Blanton L; Verani JR; Schrag SJ; Dalton AF; Wondimu MH; Link-Gelles R; Azziz-Baumgartner E; Barron MA; Gaglani M; Thompson MG; Fireman B MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(7):255-263. PubMed ID: 35176007 [TBL] [Abstract][Full Text] [Related]
13. A Nationwide Cohort Study of Delta and Omicron SARS-CoV-2 Outcomes in Vaccinated Individuals With Chronic Lung Disease. Wee LE; Tan JYJ; Chiew CJ; Abisheganaden JA; Chotirmall SH; Lye DCB; Tan KB Chest; 2024 Oct; 166(4):685-696. PubMed ID: 38871281 [TBL] [Abstract][Full Text] [Related]
14. High vaccine effectiveness against severe COVID-19 outcomes and population preventable fraction during the Omicron era in Luxembourg: A nationwide retrospective risk factor analysis. Bejko D; Ernst C; Vergison A; Stranges S; Zeegers MP; Mossong J Vaccine; 2024 Sep; 42(22):126011. PubMed ID: 38825555 [TBL] [Abstract][Full Text] [Related]
15. Effectiveness of inactivated COVID-19 vaccines in preventing COVID-19-related hospitalization during the Omicron BF.7-predominant epidemic wave in Beijing, China: a cohort study. Zhao D; Sun Y; Li J; Li X; Ma Y; Cao Z; Zhang J; Ma J; Li J; Wang Q; Suo L; Zhang D; Yang P BMC Infect Dis; 2024 Sep; 24(1):991. PubMed ID: 39289630 [TBL] [Abstract][Full Text] [Related]
16. COVID-19 Vaccination and Incidence of Pediatric SARS-CoV-2 Infection and Hospitalization. Head JR; Collender PA; León TM; White LA; Sud SR; Camponuri SK; Lee V; Lewnard JA; Remais JV JAMA Netw Open; 2024 Apr; 7(4):e247822. PubMed ID: 38652476 [TBL] [Abstract][Full Text] [Related]
17. Incidence of SARS-CoV-2 Infection, Emergency Department Visits, and Hospitalizations Because of COVID-19 Among Persons Aged ≥12 Years, by COVID-19 Vaccination Status - Oregon and Washington, July 4-September 25, 2021. Naleway AL; Groom HC; Crawford PM; Salas SB; Henninger ML; Donald JL; Smith N; Thompson MG; Blanton LH; Bozio CH; Azziz-Baumgartner E MMWR Morb Mortal Wkly Rep; 2021 Nov; 70(46):1608-1612. PubMed ID: 34793417 [TBL] [Abstract][Full Text] [Related]
18. Association of COVID-19 Vaccinations With Intensive Care Unit Admissions and Outcome of Critically Ill Patients With COVID-19 Pneumonia in Lombardy, Italy. Grasselli G; Zanella A; Carlesso E; Florio G; Canakoglu A; Bellani G; Bottino N; Cabrini L; Castelli GP; Catena E; Cecconi M; Cereda D; Chiumello D; Forastieri A; Foti G; Gemma M; Giudici R; Grazioli L; Lombardo A; Lorini FL; Madotto F; Mantovani A; Mistraletti G; Mojoli F; Mongodi S; Monti G; Muttini S; Piva S; Protti A; Rasulo F; Scandroglio AM; Severgnini P; Storti E; Fumagalli R; Pesenti A; JAMA Netw Open; 2022 Oct; 5(10):e2238871. PubMed ID: 36301541 [TBL] [Abstract][Full Text] [Related]
19. COVID-19 Incidence and Death Rates Among Unvaccinated and Fully Vaccinated Adults with and Without Booster Doses During Periods of Delta and Omicron Variant Emergence - 25 U.S. Jurisdictions, April 4-December 25, 2021. Johnson AG; Amin AB; Ali AR; Hoots B; Cadwell BL; Arora S; Avoundjian T; Awofeso AO; Barnes J; Bayoumi NS; Busen K; Chang C; Cima M; Crockett M; Cronquist A; Davidson S; Davis E; Delgadillo J; Dorabawila V; Drenzek C; Eisenstein L; Fast HE; Gent A; Hand J; Hoefer D; Holtzman C; Jara A; Jones A; Kamal-Ahmed I; Kangas S; Kanishka F; Kaur R; Khan S; King J; Kirkendall S; Klioueva A; Kocharian A; Kwon FY; Logan J; Lyons BC; Lyons S; May A; McCormick D; ; Mendoza E; Milroy L; O'Donnell A; Pike M; Pogosjans S; Saupe A; Sell J; Smith E; Sosin DM; Stanislawski E; Steele MK; Stephenson M; Stout A; Strand K; Tilakaratne BP; Turner K; Vest H; Warner S; Wiedeman C; Zaldivar A; Silk BJ; Scobie HM MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(4):132-138. PubMed ID: 35085223 [TBL] [Abstract][Full Text] [Related]
20. Impact of Long SARS-CoV-2 Omicron Infection on the Health Care Burden: Comparative Case-Control Study Between Omicron and Pre-Omicron Waves. Valdivieso-Martinez B; Lopez-Sanchez V; Sauri I; Diaz J; Calderon JM; Gas-Lopez ME; Lidon L; Philibert J; Lopez-Hontangas JL; Navarro D; Cuenca L; Forner MJ; Redon J JMIR Public Health Surveill; 2024 Sep; 10():e53580. PubMed ID: 39226091 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]